Prediction of long-term outcome of cardiac resynchronization therapy by acute pressure-volume loop measurements

European Journal of Heart Failure

Volumn 15, Issue 3, 2013, Pages 299-307

  De Roest, Gerben J ^a   Allaart, Cornelis P ^a   Kleijn, Sebastiaan A ^a,b   Delnoy, Peter Paul H M ^c   Wu, Lina ^a   Hendriks, Matthijs L ^a   Bronzwaer, Jean G F ^a   Van Rossum, Albert C ^a,b   De Cock, Carel C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^c Department of Cardiology ^*  (Netherlands)

Author keywords

Cardiac resynchronization therapy; Haemodynamic response; Long term follow up; Pressure volume loops; Pump function; Reverse remodelling

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; ISCHEMIC CARDIOMYOPATHY; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84874504747     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfs190     Document Type: Article

References (40)

1. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549.
2. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853.
3. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH, Lin H, Kong SL, Lam YM, Hill MR, Lau CP. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002;105:438-445.
4. McAlister FA, Ezekowitz J., Hooton N, Vandermeer B, Spooner C, Dryden DM, Page RL, Hlatky MA, Rowe BH. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 2007;297: 2502-2514.
5. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P, Huth C, Schondube F, Wolfhard U, Becker D, Krahnefeld O, Kirkels H. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39: 2026-2033.
6. Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y, Huvelle E, Spinelli J. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104:3026-3029.
7. Bleeker GB, Schalij MJ, van der Wall EE, Bax JJ. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006;17:899-901.
8. Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy. AmHeart J 2010;160:906-914.
9. Ypenburg C, Lancellotti P, Tops LF, Bleeker GB, Holman ER, Pierard LA, Schalij MJ, Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchro-nization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol 2007;50:2071-2077.
10. Bleeker G, Schalij MJ, Nihoyannopoulos P, Steendijk P, Molhoek SG, van Erven L, Bootsma M, Holman ER, van der Wall EE, Bax JJ. Left ventricular dyssynchrony predicts right ventricular remodeling after cardiac resynchronization therapy. J Am Coll Cardiol 2005;46:2264-2269.
11. de Cock CC, Vos DH, Jessurun E, Allaart CP, Visser CA. Effects of stimulation site on diastolic function in cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007;30 Suppl 1:S40-S42.
12. Muto C, Gasparini M, Neja CP, Iacopino S, Davinelli M, Zanon F, Dicandia C, Distefano G, Donati R, Calvi V, Denaro A, Tuccillo B. Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy-results from the LOw dose DObutamine Stress-Echo Test in Cardiac Resynchronization Therapy (LODO-CRT) Trial. Heart Rhythm 2010;7: 1600-1605.
13. Kleijn SA, van Dijk J, de Cock CC, Allaart CP, van Rossum AC, Kamp O. Assessment of Intraventricular mechanical dyssynchrony and prediction of response to cardiac resynchronization therapy: comparison between tissue Doppler imaging and real-time three-dimensional echocardiography. J Am Soc Echocardiogr 2009; 22:1047-1054.
14. Kass DA, Chen CH, Curry C, Talbot M, Berger R, Fetics B, Nevo E. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomy-opathy and ventricular conduction delay. Circulation 1999;99:1567-1573.
15. Delnoy PP, Ottervanger JP, Oude Luttikhuis H, Vos DH, Elvan A, Ramdat M, Anand R, Beukema WP, Steendijk P, van Hemel NM. Pressure-volume loop analysis during implantation of biventricular pacemaker/cardiac resynchronization therapy device to optimize right and left ventricular pacing sites. Eur Heart J 2009;22:302-307.
16. de Roest GJ, Allaart CP, de Haan S, Hendriks ML, Bronzwaer JGF, van Rossum AC, de Cock CC. Effects of QRS duration and pacing location on pressure-volume loop evaluation of cardiac resynchronization therapy in end-stage heart failure. Am J Cardiol 2011;108:1581-1588.
17. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, John Sutton M, Stewart W. Recommendations for chamber quantification. EurJ Echocar-diogr 2006;7:79-108.
18. Marsan NA, Bleeker GB, Ypenburg C, van Bommel RJ, Ghio S, Van de Veire NR, Delgado V, Holman ER, van der Wall EE, Schalij MJ, Bax JJ. Real-time three-dimensional echocardiography as a novel approach to assess left ventricular and left atrium reverse remodeling and to predict response to cardiac resynchro-nization therapy. Heart Rhythm 2008;5:1257-1264.
19. Chalil S, Foley PW, Muyhaldeen SA, Patel KC, Yousef ZR, Smith RE, Frenneaux MP, Leyva F. Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace 2007;9:1031-1037.
20. Grothues F, Smith GC, Moon JCC, Bellenger NG, Collins P, Klein HU, Pennell DJ. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34.
21. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, Abraham WT, Ghio S, Leclercq C, Bax JJ, Yu CM, Gorcsan J III, St John Sutton M, De Sutter J, Murillo J. Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation 2008;117:2608-2616.
22. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, Tockman B, Pochet T, Spinelli J. Effect of pacing chamber atrioven-tricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation 1999;99: 2993-3001.
23. Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, Halperin H, McVeigh E, Kass DA. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation 2002;106:1760-1763.
24. Nelson GS., Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation 2000;102:3053-3059.
25. St John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill M for the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation 2003;107:1985-1990.
26. Knaapen P, van Campen LMC, de Cock CC, Gotte MJW, Visser CA, Lammertsma AA, Visser FC. Effects of cardiac resynchronization therapy on myo-cardial perfusion reserve. Circulation 2004;110:646-651.
27. Delnoy PPHM, Ottervanger JP, Vos DHS, Elvan A, Misier ARR, Beukema WP, Steendijk P, van Hemel NM. Upgrading to biventricular pacing guided by pressure-volume loop analysis during implantation. J Cardiovasc Electrophysiol 2011; 22:677-683.
28. Stellbrink C, Breithardt OA, Franke A, Sack S, Bakker P, Auricchio A, Pochet T, Salo R, Kramer A, Spinelli J. Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol2001;38:1957-1965.
29. Bogaard MD, Houthuizen P, Bracke FA, Doevendans PA, Prinzen FW, Meine M, van Gelder BM. Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchroni-zation therapy. Eur J Heart Fail 2011;13:1126-1132.
30. Duckett SG, Ginks M, Shetty AK, Bostock J, Gill JS, Hamid S, Kapetanakis S, Cunliffe E, Razavi R, Carr-White G, Rinaldi CA. Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2011;58: 1128-1136.
31. Dekker AL, Phelps B, Dijkman B, van der Nagel T, van der Vee FH, Geskes GG, Maessen JG. Epicardial left ventricular lead placement for cardiac resynchroniza-tion therapy: optimal pace site selection with pressure-volume loops. J Thorac Cardiovasc Surg 2004;127:1641-1647.
32. de Roest G, Knaapen P, Gotte M, Hendriks T, Allaart C, de Cock C, van Rossum A. Stroke work or systolic dP/dtmax to evaluate acute response to cardiac resynchronization therapy: are they interchangeable? Eur J Heart Fail 2009;11:706-708.
33. Ypenburg C, Westenberg JJ, Bleeker GB, van de Veire N, Marsan N A, Henneman MM, van der Wall EE, Schalij MJ, Abraham TP, Barold SS, Bax JJ. Non-invasive imaging in cardiac resynchronization therapy-part 1: selection of patients. Pacing Clin Electrophysiol 2008;31:1475-1499.
34. van Campen CMC, Visser FC, de Cock CC, Vos HS, Kamp O, Visser CA. Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation. Heart 2006;92:1795-1800.
35. Ypenburg C, van Bommel RJ, Delgado V, Mollema SA, Bleeker GB, Boersma , Schalij MJ, Bax JJ. Optimal left ventricular lead position predicts reverse remodeling and survival after cardiac resynchronization therapy. J Am Coll Cardiol 2008;52: 1402-1409.
36. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka P. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET Study: a randomized controlled trial. J Am Coll Cardiol 2012;59:1509-1518.
37. Beshai JF, Grimm RA, Nagueh SF, Baker JH, Beau SL, Greenberg SM., Pires A, Tchou PJ. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2007;357:2461-2471.
38. Authors/Task Force Members, McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14:803-869.
39. Williams LK, Ellery S, Patel K, Leyva F, Bleasdale RA, Phan TT, Stegemann B, Paul V, Steendijk P, Frenneaux M. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony. Circulation 2009;120:1687-1694.
40. Bleeker GB, Holman ER, Steendijk P, Boersma E, van der Wall EE, Schalij MJ, Bax JJ. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 2006;48:2243-2250.